Critical Care Medicine Department, CMC Ambroise-Paré, 92200 Neuilly-sur-Seine, France.
Critical Care Medicine Department, CMC Ambroise-Paré, 92200 Neuilly-sur-Seine, France.
Arch Cardiovasc Dis. 2021 Jun-Jul;114(6-7):474-481. doi: 10.1016/j.acvd.2020.12.004. Epub 2021 Feb 6.
In cardiac surgery, risk is estimated with models such as EuroSCORE II and the Society of Thoracic Surgeons (STS) score. Performance of these scores may vary across various patient age ranges.
To assess the effect of patient age on performance of the EuroSCORE II and STS scores, regarding postoperative mortality after surgical aortic valve replacement.
In a prospective cohort of patients, we assessed risk stratification of EuroSCORE II and STS scores for discrimination of in-hospital mortality with the area under the receiver operating characteristic curve (AUROC) and calibration with the Hosmer-Lemeshow test. Two groups of patients were compared: elderly (aged>75years) and younger patients.
Of 1229 patients included, 635 (51.7%) were elderly. Mean EuroSCORE II score was 3.7±4.4% and mean STS score was 2.1±1.5%. Overall in-hospital mortality was 4.8% and was higher in the elderly compared with younger patients (6.6% vs. 2.8%; log-rank P=0.014). AUROC for the EuroSCORE II score was lower in elderly than in younger patients (0.731 vs. 0.784; P=0.025). Similarly, AUROC for the STS score was lower in elderly versus younger patients (0.738 vs. 0.768; P=0.017). In elderly patients, EuroSCORE II and STS scores were not adequately calibrated and significantly underestimated mortality. Age was independently associated with mortality, regardless of EuroSCORE II or STS score.
In this cohort, EuroSCORE II and STS scores did not perform as well in elderly patients as in younger patients. Elderly patients may be at increased postoperative risk, regardless of risk score.
在心脏外科手术中,风险通常使用 EuroSCORE II 和胸外科医师学会(STS)评分等模型进行评估。这些评分在不同年龄段的患者中表现可能存在差异。
评估患者年龄对 EuroSCORE II 和 STS 评分在外科主动脉瓣置换术后术后死亡率方面的预测性能的影响。
我们对前瞻性队列中的患者进行了评估,使用接受者操作特征曲线(ROC)下面积(AUROC)评估了 EuroSCORE II 和 STS 评分对住院死亡率的风险分层能力,并使用 Hosmer-Lemeshow 检验评估了校准度。比较了两组患者:老年(年龄>75 岁)和年轻患者。
在纳入的 1229 例患者中,有 635 例(51.7%)为老年患者。EuroSCORE II 评分的平均为 3.7±4.4%,STS 评分的平均为 2.1±1.5%。总体住院死亡率为 4.8%,老年患者高于年轻患者(6.6%比 2.8%;log-rank P=0.014)。EuroSCORE II 评分的 AUROC 在老年患者中低于年轻患者(0.731 比 0.784;P=0.025)。同样,STS 评分的 AUROC 在老年患者中低于年轻患者(0.738 比 0.768;P=0.017)。在老年患者中,EuroSCORE II 和 STS 评分校准不足,并且显著低估了死亡率。年龄与死亡率独立相关,与 EuroSCORE II 或 STS 评分无关。
在本队列中,EuroSCORE II 和 STS 评分在老年患者中的表现不如年轻患者。无论风险评分如何,老年患者术后风险可能增加。